BASILEA PHARMACEUTICA-REG/ CH0011432447 /
| 2024-05-14 5:14:56 PM | Chg. +1.50 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 44.40CHF | +3.50% | 658 Turnover: 29,019.90 |
-Bid Size: - | -Ask Size: - | 582.94 mill.CHF | - | 51.15 |
Assets
| 2018 US GAAP in mill. CHF |
2019 US GAAP in mill. CHF |
2020 US GAAP in mill. CHF |
2021 US GAAP in mill. CHF |
2022 US GAAP in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 6.4000 | 5.2000 | 2.6000 | 2.0200 | 4.2000 | ||||||
| Intangible Assets | .4000 | .4000 | .7000 | .6300 | .5800 | ||||||
| Long-Term Investments | 0.0000 | 30 | 0.0000 | 2.4000 | 1.2700 | ||||||
| Fixed Assets | 7 | 36.6000 | 6.3000 | 6.2000 | 45.4800 | ||||||
| Inventories | 14.4000 | 18.6000 | 21.2000 | 22.7800 | 24.2400 | ||||||
| Accounts Receivable | 3.8000 | 6.2000 | 8.7000 | 24.9500 | 33.1500 | ||||||
| Cash and Cash Equivalents | 173 | 109 | 60.7000 | 53.7000 | 84.6600 | ||||||
| Current Assets | 274.7000 | 184.9000 | 223.5000 | 241.0700 | 175.3600 | ||||||
| Total Assets | 281.8000 | 221.5000 | 229.8000 | 247.2700 | 220.8500 | ||||||
Liabilities
| 2018 US GAAP in mill. CHF |
2019 US GAAP in mill. CHF |
2020 US GAAP in mill. CHF |
2021 US GAAP in mill. CHF |
2022 US GAAP in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 6.4000 | 6.8000 | 13.2000 | 10.6200 | .1900 | ||||||
| Long-term debt | 197 | 197.7000 | 239.7000 | 94.5400 | 95 | ||||||
| Liabilities to Banks | 197 | 197.7000 | 239.7000 | - | - | ||||||
| Provisions | - | - | - | - | - | ||||||
| Liabilities | 348.4000 | 314.4000 | 331.8000 | 305.8700 | 241.5630 | ||||||
| Share Capital | - | - | - | - | - | ||||||
| Total Equity | -66.7000 | -93 | -102 | -58.6100 | -20.7200 | ||||||
| Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Total liabilities equity | 281.8000 | 221.5000 | 229.8000 | 247.2700 | 220.8500 | ||||||
Income Statement
| 2018 US GAAP in mill. CHF |
2019 US GAAP in mill. CHF |
2020 US GAAP in mill. CHF |
2021 US GAAP in mill. CHF |
2022 US GAAP in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 132.6000 | 134.4000 | 127.6000 | 148.1200 | 147.7700 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | -24.1000 | -17.2000 | -8.2000 | 1.1900 | 18.5400 | ||||||
| Interest Income | - | - | - | -8.0900 | -9.5500 | ||||||
| Income Before Taxes | -31.2000 | -22.4000 | -14.7000 | -6.7900 | 12.1000 | ||||||
| Income Taxes | -.2000 | 0.0000 | 0.0000 | 0.0000 | .0400 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | -31.4000 | -22.4000 | -14.7000 | 6.8300 | 12.1500 | ||||||
Per Share
Cash Flow
| 2018 US GAAP in mill. CHF |
2019 US GAAP in mill. CHF |
2020 US GAAP in mill. CHF |
2021 US GAAP in mill. CHF |
2022 US GAAP in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -79.2000 | -63.8000 | -54.1000 | -32.0200 | 7.0600 | ||||||
| Cash Flow from Investing Activities | 59.4000 | -.4000 | -35 | 3.5000 | 91.6500 | ||||||
| Cash Flow from Financing | -6 | 1.3000 | 45.1000 | 16.6400 | -45.2500 | ||||||
| Decrease / Increase in Cash | -26.8000 | -62.9000 | -44.8000 | - | - | ||||||
| Employees | 227 | 225 | 150 | 154 | 141 | ||||||
